-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Monitoring rules for toxicity in Phase II oncology trials
Anastasia Ivanova, Guochen Song, Olga Marchenko & Stergios Moschos
Clinical Trail Perspective: Clinical Investigation
-
Encouraging young men\\\\\\\'s participation in mental health research and treatment: perspectives in our technological age
Louise A Ellis, Kathryn L McCabe, Kitty A Rahilly, Mariesa A Nicholas, Tracey A Davenport, Jane M Burns & Ian B Hickie
Clinical Trail Perspective: Clinical Investigation
-
Encouraging young men\\\\\\\'s participation in mental health research and treatment: perspectives in our technological age
Louise A Ellis, Kathryn L McCabe, Kitty A Rahilly, Mariesa A Nicholas, Tracey A Davenport, Jane M Burns & Ian B Hickie
Clinical Trail Perspective: Clinical Investigation
-
Encouraging young men\\\\\\\'s participation in mental health research and treatment: perspectives in our technological age
Louise A Ellis, Kathryn L McCabe, Kitty A Rahilly, Mariesa A Nicholas, Tracey A Davenport, Jane M Burns & Ian B Hickie
Clinical Trail Perspective: Clinical Investigation
-
Encouraging young men\\\\\\\'s participation in mental health research and treatment: perspectives in our technological age
Louise A Ellis, Kathryn L McCabe, Kitty A Rahilly, Mariesa A Nicholas, Tracey A Davenport, Jane M Burns & Ian B Hickie
Clinical Trail Perspective: Clinical Investigation
-
Encouraging young men\\\\\\\'s participation in mental health research and treatment: perspectives in our technological age
Louise A Ellis, Kathryn L McCabe, Kitty A Rahilly, Mariesa A Nicholas, Tracey A Davenport, Jane M Burns & Ian B Hickie
Clinical Trail Perspective: Clinical Investigation
-
Encouraging young men\\\\\\\'s participation in mental health research and treatment: perspectives in our technological age
Louise A Ellis, Kathryn L McCabe, Kitty A Rahilly, Mariesa A Nicholas, Tracey A Davenport, Jane M Burns & Ian B Hickie
Clinical Trail Perspective: Clinical Investigation
-
Encouraging young men\\\\\\\'s participation in mental health research and treatment: perspectives in our technological age
Louise A Ellis, Kathryn L McCabe, Kitty A Rahilly, Mariesa A Nicholas, Tracey A Davenport, Jane M Burns & Ian B Hickie
Clinical Trail Perspective: Clinical Investigation
-
Encouraging young men\\\\\\\'s participation in mental health research and treatment: perspectives in our technological age
Louise A Ellis, Kathryn L McCabe, Kitty A Rahilly, Mariesa A Nicholas, Tracey A Davenport, Jane M Burns & Ian B Hickie
Clinical Trail Perspective: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation